Oncimmune Holdings (ONC) Stock Statistics & Valuation Metrics

Oncimmune Holdings has a market cap or net worth of £1.27M. The enterprise value is 17.29M.

Oncimmune Holdings has 111,773,220 shares outstanding. The number of shares has decreased by -2.65% in one year.

Oncimmune Holdings’s return on equity (ROE) is 1.51 and return on invested capital (ROIC) is -69.94%.

The current PE Ratio of Oncimmune Holdings is -3.59. Oncimmune Holdings’s PEG ratio is 0.02.

In the last 12 months, Oncimmune Holdings had revenue of 2.74M and earned -3.63M in profits. Earnings per share was -0.05.

In the last 12 months, operating cash flow was -6.13M and capital expenditures -10.00K, giving a free cash flow of -6.14M billion.

Oncimmune Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

Oncimmune Holdings upcoming earnings date is May 28, 2025, TBA Not Confirmed.

Oncimmune Holdings as a current ratio of 0.69, with Debt / Equity ratio of -213.51%

In the past 12 months, Oncimmune Holdings has paid -477.00K in taxes.

Oncimmune Holdings EV to EBITDA ratio is -5.76, with an EV/FCF ratio of -5.10.

Oncimmune Holdings has £911.00K in cash and marketable securities with £8.59M in debt, giving a net cash position of £4.35M billion.

Gross margin is 44.94%, with operating margin of -117.78%, and net profit margin of -132.46%.

The average price target for Oncimmune Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―